No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annualized revenue (TTM) · by quarter, last 12
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2021-12-31.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T11:55:32.759Z. Latest historical point 2025-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Forafric Global PLC (AFRI) stock was $11.27 as of Oct 5, 2026, 4:00 PM EDT, up 0.27% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +29.5% · 3-year avg +0.1%/yr · 5-year avg +2.3%/yr
Forafric Global PLC, with its headquarters in Gibraltar, operates as a significant enterprise within the agricultural sector, focusing its activities across Morocco and Sub-Saharan Africa. The company's operations encompass the entire supply chain for agricultural commodities and their derivatives, including sourcing, warehousing, logistics, transformation, and distribution.
Agricultural Farm Products · Gibraltar
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$44.57M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AFRI | $303.88M | $11.27 | +0.27% | +29.53% | +2.34% | N/A | N/A |
| 2CHSCP | $304.46M | $26.09 | -0.42% | -5.18% | +3.98% | +4.40% | vs AFRI |
| 3CHSCN | $301.32M | $24.35 | -0.16% | +4.21% | +4.66% | +4.82% | vs AFRI |
| 4CHSCL | $308.15M | $25.11 | +0.08% | +4.27% | +4.67% | +5.59% | vs AFRI |
| 5CHSCM | $299.35M | $23.75 | -0.46% | +1.54% | +3.76% | +4.76% | vs AFRI |
| 6CHSCO | $309.17M | $25.65 | -0.12% | +3.01% | +5.65% | +5.94% | vs AFRI |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$11.27
High
N/A
